In a final part of his interview with Pharma Commerce Editor Nicholas Saraceno, Kevin MacDonald, Bluesight’s Co-founder and CEO, explains the amount of time it takes to see a reduction in annualized drug spend, and offers estimates in terms of percent savings.
PC: Given the technological capabilities that currently exist, how long does it take to see a reduction in annualized drug spend?
MacDonald: I was talking to a health system last week, and they had sitting in current state, $1.6 million worth of savings. So just out of the gate, their perspective was, our pricing is wrong. Let's correct the pricing. That's $1.6 million savings. Then, once you get some of that low-hanging fruit of the prices that are set wrong, then you layer on.
Now the prices are changing. Do I want to make decisions about it that will change my behavior? Do I want to make some strategic changes from one drug to another? I would say that what you're typically seeing is some large fraction of a percentage savings out of the gate, and it might take you a little while to filter that through— with rebates from your wholesalers and your manufacturers—but you get to a world where you can be saving 2, 3, 4% of your drug spend in the first year, and then that continues year-over-year.
We just had one health system pass the $10 million saved mark. It’s very frequent that you're getting million-plus dollar savings in a mid-sized system within 6-12 months. It's pretty remarkable, so I'd say instantly, but you also then see that ramp up over time, and you may see different types of plays in different time horizons.
Specialty Pharmacy: The Trends Shaping Best Practices
October 2nd 2024When it comes to navigating the complex clinical and commercial landscape for specialty drugs—including hurdles in access to these critical but costly therapies—today’s specialty pharmacies are bringing more skills and services to the table.